Evidence map›Paper›PMID 28379578›Full record

ArticleSocial cognitive and affective neuroscience2017

An earlier time of scan is associated with greater threat-related amygdala reactivity.

David A A Baranger, Seth Margolis, Ahmad R Hariri, Ryan Bogdan

Registry-linked trialAbstract read
In one paragraph

Article in Social cognitive and affective neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03779477 (Effect of "Coping With Stress Program" to Depression and Anxiety Symptoms and Brain Functions in Adolescent at High-Risk for Depression), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03779477 nacompletednot on this mapstarted 2018, after this paper: background citation

Effect of "Coping With Stress Program" to Depression and Anxiety Symptoms and Brain Functions in Adolescent at High-Risk for Depression

TypeinterventionalSponsorDokuz Eylul UniversityRan2018 to 2020Enrolled57ConditionsDepressionArmsCoping with Stress Course
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Integrating sleep, neuroimaging, and computational approaches for precision psychiatry.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David A A BarangerBRAIN Laboratory, Department of Psychological and Brain Sciences, Washington University in St. Louis, St. Louis, MO 63130, USA.
Seth MargolisBRAIN Laboratory, Department of Psychological and Brain Sciences, Washington University in St. Louis, St. Louis, MO 63130, USA.
Ahmad R HaririLaboratory of NeuroGenetics, Department of Psychology and Neuroscience, Duke University, Durham, NC 27708, USA.
Ryan BogdanBRAIN Laboratory, Department of Psychological and Brain Sciences, Washington University in St. Louis, St. Louis, MO 63130, USA.

Funding

MAPPING THE HUMAN CONNECTOME DURING TYPICAL AGINGU01AG052564 · NIA · WASHINGTON UNIVERSITY · PI SALAT, DAVID H, TERPSTRA, MELISSA J · 2016 to 2020
$18.9M
Quantifying Individual Differences in Midlife Structural Brain Integrity Associated with Later AD/ADRD RiskR01AG049789 · NIA · DUKE UNIVERSITY · PI AHMAD R. HARIRI, TERRIE E MOFFITT · 2015 to 2026
$10.6M
Systems and Molecular Neurobiology Training ProgramT32GM008151 · NIGMS · WASHINGTON UNIVERSITY · PI SNYDER, LAWRENCE H · 1985 to 2019
$6.5M
GENETICS, THE ADOLESCENT BRAIN, AND ADDICTION LIABILITY: A LONGITUDINAL TWIN STUDYR01HD083614 · NICHD · WASHINGTON UNIVERSITY · PI ANOKHIN, ANDREY P. · 2016 to 2020
$3.0M
Personality and Health in Later Life: Psychosocial and Biological MechanismsR01AG045231 · NIA · WASHINGTON UNIVERSITY · PI OLTMANNS, THOMAS · 2014 to 2018
$2.9M
Self-Regulation Failure: Identifying and Modifying a Risk PhenotypeR01DA031579 · NIDA · DUKE UNIVERSITY · PI HARIRI, AHMAD R., STRAUMAN, TIMOTHY J · 2010 to 2012
$1.9M
Neurogenetic Pathways to Drug Use in Young AdultsR01DA033369 · NIDA · DUKE UNIVERSITY · PI HARIRI, AHMAD R. · 2013 to 2016
$1.4M
NIA NIH HHS R01 AG045231NIA NIH HHS R01 AG049789NIA NIH HHS U01 AG052564NICHD NIH HHS R01 HD083614NIDA NIH HHS R01 DA031579NIDA NIH HHS R01 DA033369NIGMS NIH HHS T32 GM008151
6 · The paper itself

Abstract

Time-dependent variability in mood and anxiety suggest that related neural phenotypes, such as threat-related amygdala reactivity, may also follow a diurnal pattern. Here, using data from 1,043 young adult volunteers, we found that threat-related amygdala reactivity was negatively coupled with time of day, an effect which was stronger in the left hemisphere (β = -0.1083, p-fdr = 0.0012). This effect was moderated by subjective sleep quality (β = -0.0715, p-fdr = 0.0387); participants who reported average and poor sleep quality had relatively increased left amygdala reactivity in the morning. Bootstrapped simulations suggest that similar cross-sectional samples with at least 300 participants would be able to detect associations between amygdala reactivity and time of scan. In control analyses, we found no associations between time and V1 activation. Our results provide initial evidence that threat-related amygdala reactivity may vary diurnally, and that this effect is potentiated among individuals with average to low sleep quality. More broadly, our results suggest that considering time of scan in study design or modeling time of scan in analyses, as well as collecting additional measures of circadian variation, may be useful for understanding threat-related neural phenotypes and their associations with behavior, such as fear conditioning, mood and anxiety symptoms, and related phenotypes.

Indexed as

AdolescentAdultAmygdalaAnxietyBrainCross-Sectional StudiesFearFemaleFunctional NeuroimagingHumansMagnetic Resonance ImagingMaleSleepTime FactorsYoung Adultamygdalaanxietydiurnalsleeptime

Identifiers

PMID28379578
PMCPMC5597858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.